Iovance Biotherapeutics I... (IOVA)
NASDAQ: IOVA
· Real-Time Price · USD
2.54
0.09 (3.67%)
At close: Aug 15, 2025, 3:59 PM
2.55
0.20%
After-hours: Aug 15, 2025, 07:57 PM EDT
Iovance Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -389.92M | -375.36M | -372.18M | -410M | -440.22M | -449.64M | -444.04M | -432.98M | -418.83M | -411.66M | -395.89M | -389.9M | -376.41M | -358.41M | -342.25M | -311.32M | -283.77M | -265.44M |
Depreciation & Amortization | 36.85M | 35.77M | 34.61M | 32.64M | 40.36M | 37.34M | 33.13M | 29.12M | 24.45M | 21.85M | 21.14M | 27.64M | 23.47M | 18.59M | 13.98M | 2.09M | 1.37M | 1.26M |
Stock-Based Compensation | 99.84M | 115.36M | 109.63M | 93.05M | 77.86M | 64.14M | 62.63M | 67.73M | 71.69M | 77.42M | 84.02M | 83.62M | 83.14M | 75.09M | 69.77M | 60.89M | 52.29M | 48.42M |
Other Working Capital | -11.36M | 10.19M | -5.61M | 664K | 8.65M | -5.29M | 11.6M | 11.66M | 2.98M | -3.61M | -8.78M | 3.02M | 3.67M | 17.98M | 17.58M | 7.54M | -10.97M | -3.23M |
Other Non-Cash Items | -75.2M | -83.85M | -84.23M | -85.09M | -7.42M | -4.99M | -3.54M | -2.27M | 2.79M | 3.3M | 5.13M | 2.02M | 2.85M | 2.52M | 3.95M | 10.2M | 6.65M | 7.99M |
Deferred Income Tax | 188K | -3.26M | -2.83M | -6.15M | -5.87M | -4.89M | -3.48M | -1.72M | -477K | n/a | n/a | -3.11M | -1.8M | n/a | 2.07M | 6.68M | 5.74M | 3.98M |
Change in Working Capital | 24.84M | -23.06M | -37.98M | 11.89M | -53.48M | -26.24M | -6.52M | -15.41M | -10.44M | -5.43M | -2.89M | 15.06M | 5.76M | 22.87M | 24.55M | -5.33M | -1.89M | 1.56M |
Operating Cash Flow | -303.41M | -334.39M | -352.98M | -363.65M | -388.76M | -384.28M | -361.82M | -355.52M | -335.09M | -318.77M | -292.76M | -268.94M | -262.98M | -239.35M | -227.94M | -236.78M | -219.61M | -202.23M |
Capital Expenditures | -20.13M | -13.11M | -11.07M | -10.43M | -11.72M | -20.8M | -22.29M | -21.78M | -19.59M | -14.65M | -20.43M | -24.97M | -33.27M | -38.31M | -37.57M | -53.34M | -61.5M | -56.86M |
Cash Acquisitions | n/a | n/a | -52.57M | -52.32M | -55.7M | -265.21M | -371.69M | -375.43M | -372.05M | -262.88M | -103.82M | -100.34M | -100.34M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -411.29M | -416.93M | -460.77M | -480.18M | -416.68M | -132.83M | 3.61M | 15.55M | 44.21M | -205.59M | -245.82M | -291.74M | -429.26M | -700.39M | -725.21M | -819.67M | -794.73M | -1.01B |
Sales Maturities Of Investments | 436M | 461M | 428M | 350M | 260.95M | 208.2M | 285.58M | 346.69M | 465.19M | 543.57M | 522.7M | 642.05M | 726.9M | 748.14M | 762.91M | 862.56M | 780.07M | 721.22M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -209.51M | -50.45M | -46.97M | 28.14M | 337.98M | 276.88M | 350.3M | 297.63M | 47.75M | 37.71M | 42.89M | -14.66M | -283.89M |
Investing Cash Flow | 4.58M | 30.96M | -96.41M | -192.93M | -223.15M | -420.14M | -155.24M | -81.94M | 70.79M | 323.33M | 256.45M | 325.33M | 264.37M | 9.44M | 132K | -10.45M | -76.16M | -340.75M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1M | 1M | 1M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -301K | -301K | -301K | -301K | -2.65M | -2.65M | -1.06M | -1.06M | 1.59M | 1.59M | -1K | -1K | -1K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 388.95M | 389.74M | 390.66M | -8.35M | -3.17M | -3.09M | -322K | -210K | 394K | -2.7M | 648K | 3.73M | 24.27M | 30.05M | 35.11M | 33.92M | 14.66M | 12.03M |
Financial Cash Flow | 200.81M | 340.4M | 390.66M | 389.32M | 550.16M | 398.36M | 462.96M | 652.57M | 450M | 446.9M | 190.15M | 3.73M | 24.27M | 190.32M | 239.27M | 238.08M | 218.47M | 622.95M |
Net Cash Flow | -96.69M | 37.51M | -59.19M | -163.53M | -61.26M | -409.3M | -56.84M | 209.35M | 181.94M | 451.47M | 153.85M | 60.12M | 25.66M | -39.59M | 11.46M | -9.16M | -77.29M | 79.97M |
Free Cash Flow | -323.54M | -347.5M | -364.05M | -374.08M | -400.48M | -405.08M | -384.11M | -377.3M | -354.68M | -333.42M | -313.18M | -293.91M | -296.25M | -277.66M | -265.51M | -290.13M | -281.11M | -259.09M |